Innate Pharma announces conference call and webcast for Q1 2025 business update
MARSEILLE, France–(BUSINESS WIRE)–#innatepharma–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, May 13, 2025, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2025. In addition, members … [Read more…]